HSP90AB1 and ovarian carcinoma: Thus, inhibition of cisplatin-induced DNA damage by HSP90AB1 overexpression is an important cause of resistance to chemotherapy in ovarian cancer, and ME can reverse cisplatin resistance by inhibiting HSP90AB1.